Found 7 matching trials
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant PHASE1 This phase I/II trial studies the safety and toxicity of post-transplant tr...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma PHASE2 This phase 2 trial studies how well cluster of differentiation 8 (CD8)+ mem...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies PHASE1 This phase 1 trial studies the side effects and the best dose of donor CD8+...
Show More Location
Stanford University
Learn More & Join Trial
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma PHASE1 This phase I/II trial studies the side effects and best dose of genetically...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma PHASE1 This phase I/II trial studies the side effects and best dose of genetically...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML PHASE2 This study will evaluate combining stem cells from the patient's matched si...
Show More Location
Stanford Medical Center
Learn More & Join Trial
Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia PHASE1 This phase I/II trial studies the side effects of laboratory-treated (centr...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial